Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Brain Cancer Market Size to Propel With the Active Participation of Key Leading Such as Bayer, MedImmune, Daiichi Sankyo, Genentech, Merck, and Others, Assesses DelveInsight
March 22, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 22, 2023 (GLOBE NEWSWIRE) -- Brain Cancer Market Size to Propel With the Active Participation of Key Leading Such as Bayer, MedImmune, Daiichi Sankyo, Genentech, Merck, and...
The Voice Finalist Morgan Myles Joins the Glioblastoma Foundation® as a Celebrity Ambassador to Raise Awareness and Funding for Glioblastoma
February 22, 2023 09:08 ET
|
Glioblastoma Foundation
DURHAM, N.C., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Morgan Myles was a top three finalist on the latest season of NBC's The Voice, and now she is hopeful to use her voice in a different way — to share...
The Voice Finalist Morgan Myles Joins the Glioblastoma Foundation® as a Celebrity Ambassador to Raise Awareness and Funding for Glioblastoma
February 22, 2023 09:08 ET
|
Glioblastoma Foundation
DURHAM, N.C., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Morgan Myles was a top three finalist on the latest season of NBC's The Voice, and now she is hopeful to use her voice in a different way — to share...
FLAG Therapeutics Receives Rare Pediatric Disease (RPD) Designation for FLAG-003 for the Treatment of Children with Diffuse Intrinsic Pontine Glioma (DIPG)
January 31, 2023 13:00 ET
|
Flag Therapeutics, Inc.
RALEIGH, N.C., Jan. 31, 2023 (GLOBE NEWSWIRE) -- FLAG Therapeutics, Inc., announced today that FLAG-003, an investigational small molecule therapy for the treatment of Diffuse Intrinsic Pontine...
TVAX Biomedical Announces Receipt of $2 Million FDA Orphan Products Grant for Glioblastoma Study
October 18, 2022 10:07 ET
|
TVAX Biomedical
OLATHE, Kan., Oct. 18, 2022 (GLOBE NEWSWIRE) -- TVAX Biomedical (TVAX) is a cancer immunotherapy company that is moving into its pivotal glioblastoma study for FDA regulatory approval. In September...
CNS Pharmaceuticals Inc. Featured in Syndicated Broadcast Covering Activation of First Clinical Trial Sites in Europe Evaluating Berubicin for the Treatment of GBM
October 07, 2022 08:00 ET
|
CNS Pharmaceuticals, Inc.
LOS ANGELES, Oct. 07, 2022 (GLOBE NEWSWIRE) -- InvestorWire -- CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments for...
Ivy Brain Tumor Center Implements New Liquid Biopsy Program to Provide Glioblastoma Patients More Personalized Care
September 07, 2022 09:00 ET
|
Ivy Brain Tumor Center
PHOENIX, Ariz., Sept. 07, 2022 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer, announced its...
Brain Cancer Diagnostics Market Revenue to Cross $7.37 Bn Globally, by 2028 at 28.5.% CAGR - Exclusive Report by The Insight Partners
July 15, 2022 08:30 ET
|
The Insight Partners
New York, July 15, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Brain Cancer Diagnostic Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by...
Cure Brain Cancer Foundation Invests in Innovative Clinical Trial Program to Treat Glioblastoma
May 16, 2022 06:00 ET
|
Cure Brain Cancer Foundation
LOS ANGELES, May 16, 2022 (GLOBE NEWSWIRE) -- This Brain Cancer Awareness Month (May), a handful of the brightest and best minds in brain cancer research will meet all around the US to discuss...
Telix Collaborates with Olivia Newton-John Cancer Research Institute on Brain Cancer Imaging Study
December 21, 2021 19:49 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a clinical data access agreement with...